From: Serositis as an indicator of poor prognosis in pediatric systemic lupus erythematosus
 | cSLE with large and moderate serositis (N = 15, 39.47%) | cSLE with small serositis (N = 23, 60.52%) | P-value |
---|---|---|---|
Female: Male, n (%) | 14:1 (93.3%) | 19:4 (82.60%) | 0.641 |
Age at diagnosis of SLE, mean ± SD, years | 13.40 ± 2.18 | 11.94 ± 3.50 | 0.168 |
Follow-up duration, mean ± SD, years | 5.82 ± 6.46 | 7.80 ± 5.56 | 0.344 |
Performance of effusion drainage, n (%) | 10 (66.66%) | 6 (26.08%) | 0.032 |
Modified SLEDAI-2 K, mean ± SD | 14.20 ± 4.95 | 14.78 ± 4.99 | 0.733 |
Lupus nephritis, n (%) | 12 (80%) | 19 (82.60%) | 0.821 |
End-stage renal disease, n (%) | 9 (60%) | 9 (39.13%) | 0.353 |
Mortality, n (%) | 7 (46.66%) | 8 (34.78%) | 0.694 |
Age at death, mean ± SD, years | 15.13 ± 2.49 | 18.69 ± 5.35 | 0.156 |